Agilon Health reports Q1 EPS $1.80, consensus 93c

Reports Q1 revenue $1.42B, consensus $1.38B. “Our strong first-quarter performance and increase in full-year 2026 guidance reflects disciplined execution and progress against our strategic priorities. We are seeing early returns from investments in data and technology, clinical execution, and operating discipline,” said Ronald A. Williams, Executive Chairman. “We are also strengthening our Total Care Model-expanding clinical pathways, improving quality, and deepening payor alignment-positioning us for more predictable outcomes and sustained margin expansion. We remain confident in our 2026 outlook and long-term growth trajectory.”